Lv1
70 积分 2024-10-17 加入
Stapokibart for Severe Uncontrolled Chronic Rhinosinusitis With Nasal Polyps
23天前
已关闭
Optimal Timing of Dupilumab Application in CRSwNP: Impact of “Neoadjuvant Therapy” on Surgical Outcomes at 1 Year
28天前
已完结
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
Benralizumab effect on severe chronic rhinosinusitis with nasal polyps (CRSwNP): A randomized double‐blind placebo‐controlled trial
1个月前
已关闭
Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2): phase 3, randomised, double-blind, parallel trials
1个月前
已完结
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
1个月前
已完结
Mechanisms and pathogenesis of chronic rhinosinusitis
1个月前
已完结
Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2): phase 3, randomised, double-blind, parallel trials
1个月前
已完结
Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials
1个月前
已完结
Understanding the Patient Experience of Severe, Recurrent, Bilateral Nasal Polyps: A Qualitative Interview Study in the United States and Germany
1个月前
已完结
皖公网安备34019202002308
